General Info

Celerion Inc. is the privately owned CRO formed through the acquisition of the development and regulatory services consultancy and early clinical development operations of MDS Pharma Services. The focus of the company is providing comprehensive early clinical research and bioanalytical services to the drug development community. Services provided by the company include, Clinical Research, Clinical Pharmacology Scientific Services, Medical Writing and Reporting, Bioanalytical Services, Early Cardiac Safety Services, Program Management, Regulatory Affairs and Drug Development Consultancy.